{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:30:37Z","timestamp":1783643437529,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003170","name":"Knowledge Foundation","doi-asserted-by":"publisher","award":["20190101"],"award-info":[{"award-number":["20190101"]}],"id":[{"id":"10.13039\/501100003170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["Dnr 2019-00048"],"award-info":[{"award-number":["Dnr 2019-00048"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejps.2024.106828","type":"journal-article","created":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T01:26:15Z","timestamp":1717896375000},"page":"106828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Influence of particle diameter on aerosolization performance and release of budesonide loaded mesoporous silica particles"],"prefix":"10.1016","volume":"200","author":[{"given":"Ir\u00e8s","family":"van der Zwaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia A.","family":"Pilkington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4013-9704","authenticated-orcid":false,"given":"G\u00f6ran","family":"Frenning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Valetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Pitcairn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Feiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106828_bib0001","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.xphs.2021.09.042","article-title":"In-vitro in-vivo correlation (IVIVC) of inhaled products using twin stage impinger","volume":"111","author":"Al ayoub","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2024.106828_bib0002","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11095-009-0021-1","article-title":"Understanding the behavior of amorphous pharmaceutical systems during dissolution","volume":"27","author":"Alonzo","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106828_bib0003","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/pharmrev.120.000108","article-title":"Inhaled medicines: past, present, and future","volume":"74","author":"Anderson","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejps.2024.106828_bib0004","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.fct.2007.04.001","article-title":"Five-day inhalation toxicity study of three types of synthetic amorphous silicas in Wistar rats and post-exposure evaluations for up to 3 months","volume":"45","author":"Arts","year":"2007","journal-title":"Food. Chem. Toxicol."},{"key":"10.1016\/j.ejps.2024.106828_bib0005","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/adma.200400771","article-title":"Silica particles: a novel drug-delivery system","volume":"16","author":"Barb\u00e9","year":"2004","journal-title":"Adv. Mater."},{"key":"10.1016\/j.ejps.2024.106828_bib0006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/2230-973X.160844","article-title":"Mesoporous silica nanoparticles in target drug delivery system: a review","volume":"5","author":"Bharti","year":"2015","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ejps.2024.106828_bib0007","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1089\/jam.2006.19.473","article-title":"Degree of throat deposition can explain the variability in lung deposition of inhaled drugs","volume":"19","author":"Borgstr\u00f6m","year":"2006","journal-title":"J. Aerosol. Med."},{"key":"10.1016\/j.ejps.2024.106828_bib0008","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jconrel.2024.03.013","article-title":"Inhalable porous particles as dual micro-nano carriers demonstrating efficient lung drug delivery for treatment of tuberculosis","volume":"369","author":"Campos Pacheco","year":"2024","journal-title":"J. Controll. Releas."},{"key":"10.1016\/j.ejps.2024.106828_bib0009","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11095-006-9174-3","article-title":"Particle engineering for pulmonary drug delivery","volume":"24","author":"Chow","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106828_bib0010","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/17425247.2016.1224846","article-title":"Dry powder inhalation: past, present and future","volume":"14","author":"de Boer","year":"2017","journal-title":"Exp. Opin. Drug. Deliv."},{"key":"10.1016\/j.ejps.2024.106828_bib0011","article-title":"Dry powder inhalers (DPIs), Inhaled Medicines: optimizing Development through Integration of In Silico","author":"De Boer","year":"2021","journal-title":"In Vitro In Vivo Approach. INC"},{"key":"10.1016\/j.ejps.2024.106828_bib0012","series-title":"European Pharmacopeia 9.0, Monograph 2.9.18. Preparations for Inhalation: Aerodynamic Assessment of Fine Particles","year":"2017"},{"key":"10.1016\/j.ejps.2024.106828_bib0013","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.addr.2010.11.004","article-title":"Challenges in inhaled product development and opportunities for open innovation","volume":"63","author":"Forbes","year":"2011","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2024.106828_bib0014","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1021\/acs.molpharmaceut.8b00796","article-title":"Ranking in vitro dissolution of inhaled micronized drug powders including a candidate drug with two different particle sizes","volume":"15","author":"Franek","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0015","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1021\/acs.molpharmaceut.0c00163","article-title":"Model for the analysis of membrane-type dissolution tests for inhaled drugs","volume":"17","author":"Frenning","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0016","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.tox.2012.02.001","article-title":"The toxicological mode of action and the safety of synthetic amorphous silica-A nanostructured material","volume":"294","author":"Fruijtier-P\u00f6lloth","year":"2012","journal-title":"Toxicology"},{"key":"10.1016\/j.ejps.2024.106828_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113953","article-title":"Mesoporous silica nanoparticles for pulmonary drug delivery","volume":"177","author":"Garc\u00eda-Fern\u00e1ndez","year":"2021","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2024.106828_bib0018","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/adt.2017.779","article-title":"Dissolv it : an in vitro method for simulating the dissolution and absorption of inhaled dry powder drugs in the lungs","volume":"15","author":"Gerde","year":"2017","journal-title":"Assay. Drug. Dev. Technol."},{"key":"10.1016\/j.ejps.2024.106828_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11040149","article-title":"Feasibility study of mesoporous silica particles for pulmonary drug delivery: therapeutic treatment with dexamethasone in a mouse model of airway inflammation","volume":"11","author":"Gulin-Sarfraz","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2024.106828_bib0020","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1039\/C6NR03256G","article-title":"Recent advances in chitosan-based nanoparticulate pulmonary drug delivery","volume":"8","author":"Islam","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.ejps.2024.106828_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.04.044","article-title":"Dry powder inhalers (DPIs)-A review of device reliability and innovation","volume":"360","author":"Islam","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0022","article-title":"Patent 11, 058, 832, 2021, U., 2021","author":"Lastow","year":"2021","journal-title":"Single dose dry powder inhaler"},{"key":"10.1016\/j.ejps.2024.106828_bib0023","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.addr.2014.05.017","article-title":"Delivery strategies for sustained drug release in the lungs","volume":"75","author":"Loira-Pastoriza","year":"2014","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.ejps.2024.106828_bib0024","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biologic fluids with possible application in dissolution testing","author":"Marques","year":"2011","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.ejps.2024.106828_bib0025","doi-asserted-by":"crossref","DOI":"10.1089\/jamp.2010.0836","article-title":"The Particle has Landed\u2014Characterizing the Fate of Inhaled Pharmaceuticals","volume":"23","author":"Patton","year":"2010","journal-title":"J. Aerosol. Med. Pulm. Drug. Deliv."},{"key":"10.1016\/j.ejps.2024.106828_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.03.017","article-title":"Formulation strategy and use of excipients in pulmonary drug delivery","volume":"392","author":"Pilcer","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0027","article-title":"Vitro and in vivo assessment of nanoporous amorphous particles as a potential excipient for inhaled drug products","author":"Pilkington","year":"2023","journal-title":"Drug. Delivery. to. the. Lungs."},{"key":"10.1016\/j.ejps.2024.106828_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/PDT-120027417","article-title":"Micron-size drug particles: common and novel micronization techniques","volume":"9","author":"Rasenack","year":"2004","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2024.106828_bib0029","first-page":"978","article-title":"Challenges with developing in vitro dissolution tests for orally inhaled products","volume":"13","author":"Riley","year":"2012","journal-title":"(OIPs)"},{"key":"10.1016\/j.ejps.2024.106828_bib0030","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1021\/acs.molpharmaceut.5b00221","article-title":"Evaluation of the transwell system for characterization of dissolution behavior of inhalation drugs: effects of membrane and surfactant","volume":"12","author":"Rohrschneider","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0031","doi-asserted-by":"crossref","unstructured":"Shah, N., Sandhu, H., Choi, D.S., Chokshi, H., Waseem Malick, A., 2014. Amorphous Solid Dispersions. https:\/\/doi.org\/10.1007\/978-1-4939-1598-9_13.","DOI":"10.1007\/978-1-4939-1598-9"},{"key":"10.1016\/j.ejps.2024.106828_bib0032","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/17425247.2020.1702643","article-title":"Physical stability of dry powder inhaler formulations","volume":"17","author":"Shetty","year":"2020","journal-title":"Expert. Opin. Drug. Deliv."},{"key":"10.1016\/j.ejps.2024.106828_bib0033","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2016.03.004","article-title":"Dispersibility of lactose fines as compared to API in dry powders for inhalation","volume":"504","author":"Thalberg","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0034","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1021\/acs.langmuir.7b01135","article-title":"Bare and Effective Charge of Mesoporous Silica Particles","volume":"33","author":"Valetti","year":"2017","journal-title":"Langmuir"},{"key":"10.1016\/j.ejps.2024.106828_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120609","article-title":"Can mesoporous nanoparticles promote bioavailability of topical pharmaceutics?","volume":"602","author":"Valetti","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0036","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2217\/nnm-2016-0364","article-title":"Clofazimine encapsulation in nanoporous silica particles for the oral treatment of antibiotic-resistant Mycobacterium tuberculosis infections","volume":"12","author":"Valetti","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejps.2024.106828_bib0037","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/cm0011559","article-title":"A new property of MCM-41: drug delivery system","volume":"13","author":"Vallet-Regi","year":"2001","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejps.2024.106828_bib0038","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.2c00177","article-title":"Characterization of membrane-type dissolution profiles of clinically available orally inhaled products using a Weibull Fit and a mechanistic model","author":"van der Zwaan","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122626","article-title":"A new modelling approach for dissolution of polydisperse powders","volume":"633","author":"van der Zwaan","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106828_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejps.2017.09.002","article-title":"Dry powder inhalers: an overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products","volume":"113","author":"Velaga","year":"2018","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejps.2024.106828_bib0041","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1208\/s12249-016-0544-9","article-title":"Comparison of aerodynamic particle size distribution between a next generation impactor and a cascade impactor at a range of flow rates","volume":"18","author":"Yoshida","year":"2017","journal-title":"AAPS. PharmSciTech."},{"key":"10.1016\/j.ejps.2024.106828_bib0042","unstructured":"Zhou, C., Feiler, A., Paszkiewicz, P., Xia, X., 2018. Process for manufacturing porous silica particles loaded with at least one bioactive compound adapted for lung, nasal, sublingual, and\/or pharyngeal delivery."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724001404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T03:56:41Z","timestamp":1778558201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724001404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":42,"alternative-id":["S0928098724001404"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106828","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of particle diameter on aerosolization performance and release of budesonide loaded mesoporous silica particles","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106828"}}